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Abstract 
 
This work describes a modular efficient route to 10-aza-4-thia-, 10-aza-4-oxa-, and 10-oxa-4-thia-1,7-
dioxaspiro[5.5]undecanes. The synthetic pathway relies upon the iterative nucleophilic substitution of 
1,3-dichloropropan-2-one O-benzyloxime by solketal derivatives. The oxime key-intermediates, 
submitted to an acidic deprotection–spiroacetalization process, afforded these original spiroketal 
compounds in three steps, few purifications, and very good yields. 
 
1. Introduction 
 
Spiroketals are found as crucial substructures in a wide variety of natural compounds of diverse origins.[1], 
[1a], [1b], [1c] and [1d] Due to their broad spectrum of biological activities, these moieties have therefore 
attracted considerable synthetic interest leading to numerous strategies, which have been described and 
reviewed.[1], [1a], [1d], [2], [2a], [2b], [2c], [2d], [2e], [2f] and [2g]  
Recently, it has been recognized that for spiroketal-containing drug compounds, the incorporation of a 
heteroatom at the C-4 position in one cycle of the spiranic core led to an enhancement of their activity. 
Thus, a series of new spiroketal derivatives possessing a nitrogen atom were evaluated as tachykinin 
antagonists; these spiromorpholino compounds showed a high affinity and excellent CNS penetration.[3], 
[3a] and [3b] By the same way, preparation of aza-[4] and [4b] or thia-5 analogues of the GM3 ganglioside lactone 
led to useful compounds that revealed hydrolytically stable immunogens. Lastly, the modification of the 
functionality of the tonghaosu skeleton afforded new substrates showing obvious antifeedant activity.[6], 
[6a] and [6b] 
The main approach for the synthesis of spiroketal units involves (i) elaboration of a key acyclic keto-diol 
or its equivalent[7], [7a], [7b], [7c], [7d], [7e], [7f], [7g] and [7h] via intermolecular C–C bond formations followed by (ii) 
an intramolecular acid-catalyzed dehydrative ketalization. In this approach, the control of the 
stereochemistry of the anomeric center is usually based on the relative stabilities of the different isomers 
in the spiroketalization process: when maximum anomeric effects and minimum steric interactions are 
conjugated, a thermodynamically most favored isomer is formed as the almost sole product. However, 
although this strategy has been largely reported for the synthesis of numerous spiroketal skeletons, it has 
been rarely used for the elaboration of diheteroatom-containing spiroketals. 
Indeed, and to our knowledge, only two syntheses of 1,7-dioxaspiro[5.5]undecanes incorporating 
heteroatoms at the C-4 and C-10 positions were reported (Scheme 1). The first one rested on the use of a 
d-fructose unit as chiral source.[8], [8a] and [8b] The authors employed a step-by-step nucleophilic substitution 
by chloroethanol followed by an oxidative fructose-ring opening to prepare the key intermediate 1, from 
which the 10-thia- or the 10-aza-1,4,7-trioxaspiro[5.5]undecanes 2 and 3 were elaborated, once again, 
through nucleophilic displacements. The targeted spiroketals were thus isolated as sole isomers, in seven 
steps from fructose in 19% and 33% overall yields, respectively. This approach has not been extended to 
substituted derivatives, probably because of the choice of the starting material. 
 
 
Scheme 1. 
 
The second method8c consisted of the regioselective ring opening of the 2,2-dimethyl-4-[(oxiran-2-
ylmethoxy)methyl]-1,3-dioxolane (obtained from solketal and epichlorohydrin) by the (2,2-dimethyl-1,3-
dioxolan-4-yl)methanamine, leading to the key alcohol 4. Finally, oxidation and acid-catalyzed 
deprotection–spiroketalization conduced to the 10-aza-1,4,7-trioxaspiro[5.5]undecane 5 (seven steps, 
22% overall yield) but only after modification of the nitrogen protective group. The use of an oxidation 
step in this synthetic scheme disfavored the direct introduction of a sulfur atom at C-4. 
For our part, we have recently demonstrated9 that the synthesis of ‘symmetrical’ new 1,4,7,10-
tetraoxaspiro[5.5]undecane 6a and 4,10-dithia-1,7-dioxaspiro[5.5]undecane 6b could be efficiently 
achieved through a one-step acid-catalyzed deprotection–spiroketalization from the elaborated key 
oximes 7a,b; these latter being readily synthesized by a one-step double substitution of 1,3-
dichloropropan-2-one O-benzyloxime 8 by solketal 9a or its thiol derivative 9b (Scheme 2). 
Disappointingly, this synthetic pathway revealed ineffective to elaborate the biologically interesting 4,10-
aza-1,7-dioxaspiro[5.5]undecane framework 6c and led to the 3-aza-6,8-dioxabicyclo[3.2.1]octan-2-one 
10 in place of the spiranic system (Scheme 2). With oxime 7c, the presence of amine functions made 
critical the final spirocyclization and gave numerous by-products.10 
 
 
Scheme 2. 
Nevertheless, and even if spirobismorpholines could not be obtained, we pursued the study of this 
strategy to elaborate this time ‘dissymmetrical’ spiroketals possessing different heteroatoms in C-4 and C-
10 positions. In this paper, we would like to present our results toward the successful syntheses of three 
families of original compounds owning a 2,8-dihydroxymethyl-4-thia-1,7,10-trioxaspiro[5.5]undecane, a 
2,8-dihydroxymethyl-10-aza-4-thia-1,7-dioxaspiro[5.5]undecane, and a 2,8-dihydroxymethyl-10-aza-
1,4,7-trioxaspiro[5.5]undecane skeleton. 
 
2. Results and discussion 
 
The crucial point for the elaboration of these spiroketals was the efficient control of the monosubstitution 
of 1,3-dichloropropan-2-one O-benzyloxime 8 by solketal derivatives 9. 
In the conditions used for oxa- and thia-series 6a,b—alkali hydrides treatment—mono-substituted oximes 
were detected during the TLC monitoring as the first product of the reaction but usually very fast 
accompanied with the disubstituted compounds.9 We therefore undertook a study of the best operating 
conditions in terms of base, concentration ratio, solvent, and temperature to obtain oximes 11a,b from 8 
and 9a,b and avoid the more favored double substitution. In all cases, reactions were TLC-monitored and 
quenched at the appearance of disubstituted oximes 7. From alkali hydrides, best results were obtained by 
carrying out the reaction in tetrahydrofuran (1 mmol of 8/3 mL of solvent) at 20 °C, with an addition of 
1 equiv of alcohol 9a or freshly prepared thiol 9b on a mixture of oxime 8 and 2 equiv of alkali hydride. 
These conditions led to the expected chlorides 11a and 11b in 30% and 64% yields, respectively, 
accompanied with only 5–10% of the corresponding undesired bi-adduct 7a or 7b. Unreacted starting 
materials 9a and 9b could be recycled from flash column chromatography. In the case of 11a, better 
yields— even if more wavering, from 40% to 60% yield—were obtained using a similar procedure as that 
previously described for the synthesis of 4-hydroxymethyl-1,3-dioxolane ethers:11 namely, treatment of 
solketal by potassium hydroxide in toluene at 70 °C followed by the slow addition of an excess 
(1.5 equiv) of oxime 8 (Scheme 3). 
 
 
Scheme 3. Reagents and conditions: (a) KH (2 equiv), THF, 20 °C, 30%; (b) KOH (1 equiv), 18-C-6 
(0.5 equiv), toluene, 70 °C, 40–60%; (c) NaH (2 equiv), THF, 20 °C, 64%; (d) two steps, 28% overall 
yield.10 
Compound 11a appeared as a mixture of Z and E isomers in a 1/1 ratio determined from the 1H NMR 
spectrum, whereas compound 11b was a mixture of the two isomers in a 3/2 ratio in favor of the Z one.12 
Concerning the synthesis of ‘aza-monooximes’, our exploratory work in this area10 has shown that 
nitrogen atoms implied in amine function (i.e., oxime 7c, Scheme 2) hindered the final spiroketalization 
carried out under acidic conditions. Furthermore, the extensive study toward aza-substitution of oxime 8 
allowed us to prepare the monochlorooxime 11c10 issued from 8 and the Boc-derivative of 9c in a correct 
yield of 33% (Scheme 3). Consequently, this kind substrate had also been considered for the synthesis of 
new ‘dissymmetrical’ 4-aza-1,7-dioxaspiro[5.5]undecanes. 
With the mono-substituted chlorooximes 11a–c in hands, we engaged them in spiroketal synthesis. 
Considering our previous results in the symmetrical series, we first explored the access to 2,8-
dihydroxymethyl-4-thia-1,7,10-trioxaspiro[5.5]undecane 13. This was realized according to two parallel 
pathways using both 11a and 11b as key building blocks (Scheme 4). Thus, conversion of 11a,b to the 
required oxime 12 was achieved using KH in tetrahydrofuran at 20 °C, and gave, after purification, oxime 
12 in 86% yield (from 11a and 7b) and 54% yield (from 11b and 7a), respectively. Compound 12 
appeared as a mixture of Z and E isomers (3/2 ratio determined on 1H NMR spectrum) easily identified 
by the chemical shift of the methylene group in the α position of the benzyloxime function.12 Lastly, 
oxime 12 was heated under reflux for 2 days in an acetone/water solution in the presence of Amberlyst® 
15. In this case and as in 4,10-dithia-1,7-dioxaspiro[5.5]undecane series, the addition of 10 equiv of 
paraformaldehyde was necessary to achieve efficiently the ketone deprotection and promote the 
spiroketalization (Scheme 4). Spiroketal 13 was thus obtained in 79% yield as a mixture of two 
inseparable isomers 13a/13b in a 19/1 ratio as determined on the quantitative 13C NMR spectrum. 
  
Scheme 4. Reagents and conditions: (a) KH, THF, 7b or 7a, 20 °C (86% from 11a, 54% from 11b); (b) 
Amberlyst® 15, (CH2O)n, acetone/H2O (10:1), ∆, 48 h, 79%. 
 
This result was in agreement with those observed in the symmetrical series.9 Indeed, in our 
spirocyclisation acid-catalyzed conditions, dioxa-spiroketal 6a (Scheme 1) was isolated as a sole isomer, 
possessing a C2 symmetry with a double anomeric effect, having two cycles in a chair conformation and 
the hydroxymethyl groups in an equatorial position. Conversely, we observed for dithia-spiroketal 6b a 
loss of stereoselectivity due to the presence of the less electron-withdrawing sulfur atom. Thus, starting 
from enantiopure solketal 9a, we isolated a mixture of two C-6 epimers. 
The major isomer 13a could be isolated and characterized after a classical TBDPS-
protection/deprotection sequence. Its 13C NMR spectrum comprised nine peaks with a spiranic carbon 
detected at 92.3 ppm (see Table 1). In the 1H NMR spectrum, H-2 (δ=4.06 ppm) and H-8 (δ=4.02 ppm) 
exhibited vicinal coupling constants 3J with H-3 and H-9 of 11.0 and 2.0 Hz, 11.0 and 2.5 Hz, 
respectively. Thus, 13a adopted a chair conformation for its two cycles with H-2 and H-8 in an axial 
position. Moreover, structural data for 13a fitted with those of (6S)-2,8-dihydroxymethyl-4,10-dithia-1,7-
dioxaspiro[5.5]undecane 6b for its A cycle and (6S)-2,8-dihydroxymethyl-1,4,7,10-
tetraoxaspiro[5.5]undecane 6a for its B cycle (see Table 1): for instance, C-3 was found at 27.5 ppm and 
C-9 at 68.7 ppm. The values of the chemical shifts of C-2 and C-8 in 13a, are also similar to those 
observed in the symmetrical series. Because of the oxathiane–dioxane sequence, the chemical shifts of C-
5 and C-11 were slightly modified and were observed, now, at 31.0 ppm and 72.9 ppm, respectively. 
Their corresponding hydrogens were shielded for H-5 and deshielded for H-11. 
Table 1.  
NMR data for ‘symmetrical’ and ‘dissymmetrical’ spirobisdioxanes 6a,9 spirobisoxathianes 6b,9 and 
spirodioxane–oxathiane 13a (recorded at 400 MHz, measured in CD3OD) 
 
   
 δH, J in Hz δC δH, J in Hz δC δH, J in Hz δC 
2 4.03, dtd, 11.0, 5.0, 3.0 70.2 4.06, dddd, 11.0, 6.0, 5.0, 2.0 72.0 3.97, dt, 11.5, 5.0 72.4
3 3.37, t, 11.0; 3.80, dd, 11.0, 3.0 68.8 
2.37, dt, 13.0, 2.0; 2.57, 
dd, 13.0, 11.0 27.5
2.37, d, 11.5; 2.54, t, 
11.5 27.8
5 3.24, d, 11.5; 3.55, d, 11.5 69.6 
2.31, dd, 13.5, 1.5; 2.68, 
d, 13.5 31.0
2.40, d, 13.5; 2.76, d, 
13.5 35.2
6  93.0  92.3  91.9
8 4.03, dtd, 11.0, 5.0, 3.0 70.2 4.02, dtd, 11.0, 5.0, 2.5 70.4 3.97, dt, 11.5, 5.0 72.4
    
 δH, J in Hz δC δH, J in Hz δC δH, J in Hz δC 
9 3.37, t, 11.0; 3.80, dd, 11.0, 3.0 68.8 
3.41, t, 11.0; 3.84, dd, 
11.5, 2.5 68.7
2.37, d, 11.5; 2.54, t, 
11.5 27.8
11 3.24, d, 11.5; 3.55, d, 11.5 69.6 
3.34, d, 11.5; 3.62, d, 
11.5 72.9
2.40, d, 13.5; 2.76, d, 
13.5 35.2
CH2OH 
3.51, dd, 12.0, 5.0; 3.55, 
dd, 12.0, 5.0 62.9 
3.49, dd, 11.5, 5.0; 3.56, 
dd, 11.5, 6.0 65.9
3.48, dd, 11.5, 5.0; 3.56, 
dd, 11.5, 5.0 65.9
CH2OH 
3.51, dd, 12.0, 5.0; 3.55, 
dd, 12.0, 5.0 62.9 
3.57, dd, 12.0, 5.0; 3.60, 
dd, 12.0, 5.0 62.8
3.48, dd, 11.5, 5.0; 3.56, 
dd, 11.5, 5.0 65.9
 
From all these data, and as the configuration of C-2 and C-8 was governed by that of starting materials 9a 
and 9b, isomer 13a adopted necessarily a structure stabilized by a double anomeric effect and equatorial 
positions for its substituents, with a (2R,6S,8R) configuration. Starting from 1,3-dichloropropan-2-one, 
this spiranic oxathiane–dioxane system was obtained in four steps, and 28–34% range overall yield 
depending of the order of introduction of oxa- and thia-synthons 9a,b. 
At this stage of the work, the examination of the more doubtful synthesis of aza-spiroketals remained 
unsolved. We began our investigation starting from the monochlorooxime 11c, from which oxa- and thia-
compounds could be envisioned. Substitution of 11c by the thio-solketal 9b was efficiently accomplished 
using KH in THF and furnished 14 in 81% yield (Scheme 5). The assignment of all signals in the 1H and 
13C NMR spectra was in this case complicated by the existence of rotamers due to the carbamate group, 
together with the presence of the two Z and E isomers. 
 
 
Scheme 5. Reagents and conditions: (a) KH, THF, 81%; (b) Amberlyst® 15, acetone/H2O (10:1), ∆, 4 h, 
33%; (c) ∆. 
Treatment of 14 in our classical acidic medium afforded after 4 h at reflux the tetraol 15 as the sole 
product of the reaction. Pursuing the heating, we observed the disappearance of 14 (TLC monitoring) 
accompanied by the formation of numerous side-products lacking the Boc group in their skeleton 
(checked by 1H NMR spectrum). At ambient temperature and even after 4 days, the oxime function of 15 
remained unchanged. 
At this stage, the reactivity of the Boc group under our acid-heating conditions, together with the trouble 
to obtain in good yields aza-protected chlorooximes 11,10 prompted us to investigate the synthesis of 
spiromorpholines from the monochlorooximes 11a,b, testing their reactivity toward amine 9c (Scheme 6). 
 
 
 
Scheme 6. Reagents and conditions: (a) MeOH, ∆, 9c, 8 h, 61% from 11a, 67% from 11b; (b) PhCOCl, 
NEt3, DMAP, CH2Cl2, 0 °C, 90% from 16, 95% from 17; (c) Amberlyst® 15, (CH2O)n, acetone/H2O 
(10:1), ∆, 61% from 18, 65% from 19; (d) LiAlH4, THF, nearly quantitative. 
Oximes 11a,b were heated in boiling methanol during 8 h in the presence of 3 equiv of amine 9c. Under 
these conditions, only monosubstitution was observed, leading to oxime 16 in 61% yield as a mixture of 
E/Z isomers (5/3 ratio determined on the 1H NMR spectrum) and oxime 17 in 67% yield as a 1/3 mixture 
of E/Z isomers. Compounds 16 and 17 were then treated by freshly distilled benzoylchloride in presence 
of NEt3 and DMAP in dichloromethane to furnish the attempted amides 18 and 19 in 90% and 95% 
yields, respectively. The final deprotection–spiroketalization step was then carried out as usual, through 
the addition of paraformaldehyde to regenerate the keto-function. The targeted spiromorpholinoketals 20 
and 21 were obtained in 61% and 65% yields, respectively. No other derivatives were detected in the 
crude reaction mixture. 
Finally, compounds 20 and 21 were obtained from 1,3-dichloropropan-2-one in five steps in 17% and 
26% overall yields, respectively. Full structural characterization of 20 and 21 could not be achieved at 
ambient temperature, as 1H spectra were typical of coalescence phenomena and 13C NMR spectra 
revealed mixtures of spiranic compounds. From 13C NMR spectrum recorded at 70 °C, each compound, 
20 and 21, appeared clearly as a mixture of two inseparable isomers. The attribution of 13C chemical 
shifts of the major and minor ones could be realized at this stage and, in the case of 20, spectroscopic data 
were correlated with those already published in the literature.8c 
To overcome the problem of coalescence and determine without ambiguity the structure of each major 
isomer of 20 and 21, we reduced their amide function. The full cleavage of the amido group was 
efficiently accomplished using a large excess of LiAlH4 in THF,[13], [13a] and [13b] furnishing the 
spiromorpholines 22 and 23 as, once again, a mixture of inseparable isomers in a 4/1 ratio for 22 and 9/1 
ratio for 23. Finally, major compounds could be isolated and characterized through their derivatization as 
silylether derivatives (TBDPS-protection/Bu4NF deprotection). 
Spiranic carbons of major isomers 22a and 23a were detected at 91.6 ppm (22a) and 90.9 ppm (23a). 
These values were once again in agreement with those observed for (6S)-spiro[5.5]undecane series. The 
C-3 and C-9 appeared at 67.2 ppm (22a)–66.2 ppm (23a) and 46.1 ppm (22a and 23a), respectively. 
Major isomers adopted a chair conformation for the two cycles as evidenced by (i) H-9ax and H-3ax that 
were detected as triplets with 2J=3J=12.0 Hz, and (ii) H-9eq and H-3eq resonating either as broad doublets 
(2J=12.0 Hz) or dedoubled doublet (2J=12.0 Hz, 3J=2.5 Hz). From all spectroscopic data, we assumed that 
majors isomers were the (2R,6S,8S)-22a and the (2R,6S,8S)-23a. 
 
3. Conclusion 
 
To summarize, we have developed an original and efficient pathway to new 1,7-dioxaspiro[5.5]undecanes 
incorporating in their skeleton two different heteroatoms in positions 4 and 10. Starting from 
commercially available (S)-solketal and 1,3-dichloropropan-2-one, we have shown that, in few steps and 
with good overall yields, we were able to elaborate in a modular way, spiranic systems based on the 
association of dioxane–oxathiane, dioxane–morpholine, and oxathiane–morpholine cores. Finally, this 
work completed and generalized our previous study in the ‘symmetrical’ series, namely spirobisdioxane 
and spirobisoxathiane systems. 
 
4. Experimental section 
4.1. General experimental methods 
 
Infrared spectra were recorded on a Perkin–Elmer 881 instrument. 1H NMR (400 MHz) and 13C NMR 
(100 MHz) were recorded with a BRUKER AC 400 spectrometer. Chemical shifts (δ values) are 
expressed in parts per million (ppm), coupling constants (J) are expressed in hertz, and multiplicities are 
mentioned as follows: s (singlet), d (doublet), t (triplet), q (quartet), Q (quintet), m (multiplet). NMR 
spectra were recorded in CDCl3, CD3OD or DMSO-d6, using the solvent signals as reference. Mass 
spectra were recorded with a Hewlett Packard 5989B instrument and high resolution mass spectra 
(HRMS) were performed with a Q-TOF micromass. Chromatography was performed using silica gel 60 
(230–400 mesh) and thin layer chromatography (TLC) was performed on silica gel 60PF254 plates 
(20×20 cm). Compounds were identified using UV fluorescence (λ=254 nm) and/or staining with a 5% 
phosphomolybdic acid solution in ethanol following by heating. Commercially reagents (Aldrich, Acros, 
Lancaster) were used as received without additional purification. Tetrahydrofuran (THF) was distilled 
from potassium/benzophenone while dichloromethane (CH2Cl2) was dried over calcium hydride prior to 
use. 
 
4.2. Synthesis 
4.2.1. (2E)- and (2Z)-1-Chloro-3-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy}propanone O-benzyloxime (11a) 
 
Method A. To a solution of oxime 8 (2.11 g, 9.1 mmol) and KH (2.44 g, 18.2 mmol) in THF (3 mL) was 
added (S)-9a (1.21 g, 9.1 mmol) and the resulting mixture was stirred until disubstituted compound was 
detected on TLC. The reaction was stopped by addition of a saturated solution of NH4Cl. After extraction 
with ethyl acetate, the crude solution was concentrated in vacuo and purified by flash chromatography 
using (19:1→7:3) cyclohexane/ethyl acetate as eluent to give pure 11a as a colorless liquid (0.90 g, 30%). 
Method B. To a solution of (S)-9a (0.330 g, 2.5 mmol) in toluene (10 mL) were added KOH (0.165 g, 
2.5 mmol) and 18-crown-6 (0.330 g, 1.25 mmol). The resulting mixture was heated at 70 °C for 1 h 
before addition, at 70 °C and over a period of 1 h, of a solution of oxime 8 (0.580 g, 2.5 mmol) in toluene 
(5 mL). At the appearance of disubstituted compound, reaction is stopped by addition of water. The 
resulting mixture is concentrated in vacuo and layers were separated. After extraction of the aqueous one 
by ethyl acetate, the combined organic layers are dried and concentrated. A final purification by flash 
chromatography using (4:1→1:1) cyclohexane/ethyl acetate as eluent furnished pure 11a in a 40–60% 
yield. 
Compound 11a: IR νmax (neat, cm−1) 1600 (C N), 1250–1040 (C–O); 1H NMR (CDCl3) δ/ppm 7.40–
7.30 (m, 10H, H–Ar, E and Z), 5.17 (s, 2H, CH2Ph, Z), 5.11 (s, 2H, CH2Ph, E), 4.48 (d, J=15.0 Hz, 1H, 
O–CH2–C , E), 4.44 (d, J=15.0 Hz, 1H, O–CH2–C , E), 4.27 (Q, J=6.0 Hz, 1H, CH–O, E), 4.26 (m, 
1H, CH–O, Z), 4.23 (d, J=11.5 Hz, 1H, CH2Cl, E), 4.21 (d, J=11.5 Hz, 1H, CH2Cl, E), 4.21 (m, 2H, O–
CH2–C , Z), 4.20 (m, 1H, CH2Cl, Z), 4.19 (d, J=11.5 Hz, 1H, CH2Cl, Z), 4.05 (t, J=7.0 Hz, 1H, CH2–O, 
E), 4.03 (t, J=6.5 Hz, 1H, CH2–O, Z), 3.77 (dd, J=8.0, 6.5 Hz, 1H, CH2–O, E), 3.70 (dd, J=8.0, 6.5 Hz, 
1H, CH2–O, Z), 3.55 (dd, J=10.0, 5.5 Hz, 1H, CHO–CH2O, E), 3.50 (dd, J=10.0, 5.0 Hz, 1H, CHO–
CH2O, E), 3.49 (dd, J=10.0, 5.5 Hz, 1H, CHO–CH2O, Z), 3.44 (dd, J=10.0, 5.0 Hz, 1H, CHO–CH2O, Z), 
1.42 (s, 6H, Me, E and Z), 1.36 (s, 6H, Me, E and Z); 13C NMR (CDCl3) δ/ppm 154.9 (C N, E), 152.4 
(C N, Z), 137.1 (C–Ar, Z), 137.0 (C–Ar, E), 128.4 (C–Ar, Z and E), 128.1 (C–Ar, Z), 128.0 (C–Ar, E), 
127.9 (C–Ar, Z and E), 109.5 (C–(CH3)2, E), 109.4 (C–(CH3)2, Z), 76.7 (CH2Ph, E), 76.5 (CH2Ph, Z), 
74.4 (CH–O, E), 74.3 (CH–O, Z), 72.3 (CHO–CH2O, E), 71.3 (CHO–CH2O, Z), 69.3 (O–CH2–C , Z), 
66.5 (CH2–O, E and Z), 63.9 (O–CH2–C , E), 41.1 (CH2Cl, E), 32.7 (CH2Cl, Z), 26.7 (CH3, E), 26.6 
(CH3, Z), 25.3 (CH3, Z and E). Anal. Calcd for C16H22ClNO4: C, 58.62; H, 6.76; Cl, 10.82; N, 4.27. 
Found C, 58.57; H, 6.79; Cl, 10.72; N, 4.25. 
4.2.2. (2E)- and (2Z)-1-Chloro-3-({[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}thio)propanone O-benzyloxime (11b) 
To a solution of oxime 8 (0.254 g, 1.1 mmol) and NaH (0.090 g, 2.2 mmol) in THF (3 mL) was added 
(R)-9b (0.200 g, 1.1 mmol) and the resulting mixture was stirred until disubstituted compound was 
detected on TLC. The reaction was stopped by addition of a saturated solution of NH4Cl (2 mL). After 
extraction with ethyl acetate, the crude solution was concentrated in vacuo and purified by flash 
chromatography using (19:1→4:1) cyclohexane/ethyl acetate as eluent to give pure 11b as a colorless oil 
(0.255 g, 64%). IR νmax (neat, cm−1) 1618 (C N), 1250–1040 (C–O); 1H NMR (CDCl3) δ/ppm 7.38–
7.30 (m, 10H, H–Ar, E and Z), 5.14 (s, 2H, CH2Ph, Z), 5.11 (s, 2H, CH2Ph, E), 4.37 (s, 2H, CH2Cl, Z), 
4.29 (d, J=11.5 Hz, 1H, CH2Cl, E), 4.26 (d, J=11.5 Hz, 1H, CH2Cl, E), 4.19 (Q, J=6.0 Hz, 1H, CH–O, E), 
4.17 (Q, J=6.0 Hz, 1H, CH–O, Z), 3.99 (dd, J=8.5, 6.0 Hz, 1H, CH2–O, Z), 3.95 (dd, J=8.5, 6.0 Hz, 1H, 
CH2–O, E), 3.60 (d, J=13.5 Hz, 1H, S–CH2–C , E), 3.55 (d, J=13.5 Hz, 1H, S–CH2–C , E), 3.59 (dd, 
J=8.5, J=6.0 Hz, 1H, CH2–O, E), 3.57 (dd, J=8.5, 6.0 Hz, 1H, CH2–O, Z), 3.40 (d, J=14.0 Hz, 1H, S–
CH2–C , Z), 3.37 (d, J=14.0 Hz, 1H, S–CH2–C , Z), 2.63 (dd, J=13.5, 6.0 Hz, 1H, CH–CH2S, E), 2.56 
(dd, J=13.5, 6.5 Hz, 1H, CH–CH2S, Z), 2.52 (dd, J=13.5, 6.5 Hz, 1H, CH–CH2S, E), 2.45 (dd, J=13.5, 
6.0 Hz, 1H, CH–CH2S, Z), 1.41 (s, 3H, Me, Z), 1.40 (s, 3H, Me, E), 1.34 (s, 3H, Me, Z), 1.32 (s, 3H, Me, 
E); 13C NMR (CDCl3) δ/ppm 153.4 (C N, E), 152.0 (C N, Z), 137.3 (C–Ar, Z), 136.7 (C–Ar, E), 
128.4 (C–Ar, Z and E), 128.1 (C–Ar, E), 128.0 (C–Ar, Z), 127.9 (C–Ar, Z and E), 109.5 (C–(CH3)2, Z and 
E), 76.6 (CH2Ph, E), 76.4 (CH2Ph, Z), 74.9 (CH–O, Z), 74.8 (CH–O, E), 68.6 (CH2–O, Z), 68.5 (CH2–O, 
E), 42.5 (CH2Cl, E), 35.1 (CHO–CH2S, E), 34.0 (CHO–CH2S, Z), 33.7 (CH2Cl, Z), 32.9 (S–CH2–C , 
Z), 26.9 (CH3, Z and E), 25.5 (CH3, Z), 25.4 (CH3, E), 24.4 (S–CH2–C , E); HRMS (ESI): calculated for 
C16H22ClNO3Na [M+Na]+ 366.0907, found 366.0892. 
4.2.3. (2Z)- and (2E)-1-{[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methoxy}-3-({[(4R)-2,2-dimethyl-1,3-dioxolan-4-
yl]methyl}thio)propanone O-benzyloxime (12) 
To a pre-washed KH (1.35 g, 10.4 mmol) solution in THF (10 mL) was added, under argon, thiol (R)-9b 
(0.850 mg, 5.7 mmol) in THF (10 mL) followed after 15 min by a solution of 11a (1.70 g, 5.2 mmol) in 
THF (20 mL). After the completion of the reaction (disappearance of 11a), water was added and the 
resulting solution was extracted with dichloromethane. The organic layer was concentrated in vacuo and 
purified by flash chromatography using (9:1) cyclohexane/ethyl acetate to give 12 (2.0 g, 86%) as a 
colorless oil of a mixture of Z and E isomers. 
The same protocol applied to 11b (0.200 g, 0.58 mmol) and (S)-solketal 9a (0.092 mg, 0.70 mmol) using 
KH (0.155 g, 1.16 mmol) gave, after purification, 12 (0.138 g, 54%). 
Compound 12: IR νmax (neat, cm−1) 1600 (C N), 1250–1050 (C–O); 1H NMR (CDCl3) δ/ppm 7.40–7.25 
(m, 10H, H–Ar, E and Z), 5.09 (s, 2H, CH2Ph, Z), 5.06 (s, 2H, CH2Ph, E), 4.46 (d, J=15.0 Hz, 1H, O–
CH2–C N, E), 4.43 (d, J=15.0 Hz, 1H, O–CH2–C N, E), 4.25 (Q, J=6.0 Hz, 1H, CH–O, E), 4.24 (Q, 
J=6.0 Hz, 1H, CH–O, Z), 4.20 (Q, J=6.5 Hz, 1H, CH–O, Z), 4.20 (d, J=12.0 Hz, 1H, O–CH2–C N, Z), 
4.18 (Q, J=6.0 Hz, 1H, CH–O, E), 4.17 (d, J=12.0 Hz, 1H, O–CH2–C N, Z), 4.03 (dd, J=8.5 and 
6.5 Hz, 1H, O–CH2–CHO, E), 4.02 (dd, J=8.5 and 6.5 Hz, 1H, O–CH2–CHO, Z), 4.00 (dd, J=8.5 and 
6.0 Hz, 1H, O–CH2–CHO, E), 3.95 (dd, J=8.5 and 6.0 Hz, 1H, O–CH2–CHO, Z), 3.74 (dd, J=8.5 and 
6.5 Hz, 1H, O–CH2–CHO, E), 3.68 (dd, J=8.5 and 6.5 Hz, 1H, O–CH2–CHO, Z), 3.59 (dd, J=8.5 and 
6.5 Hz, 2H, O–CH2–CHO, E and Z), 3.53 (dd, J=10.0 and 5.5 Hz, 1H, CHO–CH2–O–CH2–, E), 3.48 (d, 
J=13.5 Hz, 1H, S–CH2–C N, Z), 3.48 (dd, J=10.0 and 5.5 Hz, 1H, CH2–OCH2C N, E), 3.47 (dd, 
J=10.0 and 6.0 Hz, 1H, CH2–OCH2C N, Z), 3.46 (d, J=13.5 Hz, 1H, S–CH2–C N, Z), 3.42 (dd, 
J=10.0 and 5.0 Hz, 1H, CH2–OCH2C N, Z), 3.34 (d, J=13.5 Hz, 1H, S–CH2–C N, E), 3.30 (d, 
J=13.5 Hz, 1H, S–CH2–C N, E), 2.68 (dd, J=13.5 and 6.0 Hz, 1H, S–CH2–CHO, Z), 2.62 (dd, J=13.5 
and 6.0 Hz, 1H, S–CH2–CHO, E), 2.55 (dd, J=13.5 and 6.5 Hz, 1H, S–CH2–CHO, Z), 2.49 (dd, J=13.5 
and 6.5 Hz, 1H, S–CH2–CHO, E), 1.41 (s, 9H, Me), 1.40 (s, 3H, Me), 1.35 (s, 6H, Me), 1.34 (s, 3H, Me), 
1.32 (s, 3H, Me); 13C NMR (CDCl3) δ/ppm 155.9 (C N, E), 154.6 (C N, Z), 137.6 (C–Ar, E), 137.1 
(C–Ar, Z), 128.4 (C–Ar, Z and E), 128.3 (C–Ar, Z), 128.2 (C–Ar, Z), 128.0 (C–Ar, E), 127.9 (C–Ar, E), 
109.5 (C–(CH3)2, Z),109.4 (C–(CH3)2, E), 76.2 (CH2Ph Z), 76.1 (CH2Ph, E), 74.9 (CH–O, E), 74.8 (CH–
O, Z), 74.5 (CH–O, Z), 74.4 (CH–O, E), 72.2 (CHO–CH2O, E), 71.2 (CHO–CH2O, Z), 69.4 (O–CH2–
C N, Z), 68.8 (O–CH2–CHO, E), 68.6 (O–CH2–CHO, Z), 66.5 (O–CH2–CHO, Z and E), 64.5 (O–CH2–
C N, E), 35.2 (S–CH2–CHO, Z), 34.1 (S–CH2–CHO, E), 31.2 (N C–CH2–S, E), 26.9 (CH3, Z and E), 
26.7 (CH3, Z and E), 25.6 (CH3, Z and E), 25.4 (CH3, E), 25.3 (CH3, Z), 24.5 (N C–CH2–S, Z). Anal. 
Calcd for C22H33NO6S: C, 60.11; H, 7.57; N, 3.1. Found: C, 60.21; H, 7.51; N, 3.29. 
4.2.4. 2,8-Dihydroxymethyl-4-thia-1,7,10-trioxaspiro-[5.5]undecane (13) 
A solution of (S,R)-12 (0.500 g, 1.14 mmol) in 10 mL of a mixture (10:1, v/v) of acetone/water, 
Amberlyst®15 (0.250 g), and paraformaldehyde (0.034 g, 1.14 mmol) was heated under reflux for 48 h. 
After cooling, the mixture was filtered on a Celite® pad. The residue was purified by column 
chromatography on silica gel using gradient (1:0→49:1) ethyl acetate/methanol as eluent, which gave a 
19:1 mixture of isomers 13 (0.185 g, 79%). IR νmax (neat, cm−1) 3400 (O–H); 13C NMR (CD3OD) δ/ppm 
107.0–92.3 (C-6), 75.6–72.9 (C-11), 75.9–72.0 (C-2), 72.1–70.4 (C-8), 74.4–68.7 (C-9), 65.9 (C-12), 
64.3–62.8 (C-13), 32.2–31.0 (C-5), 29.8–27.5 (C-3). 
Major compound: (2R,6S,8R)-13a: 1H NMR (CDCl3) δ/ppm 4.06 (dddd, J2ax3ax=11.0 Hz, J2ax12a=6.0 Hz, 
J2ax12b=5.0 Hz, J2ax3eq=2.0 Hz, 1H, H-2ax), 4.02 (dtd, J8ax9ax=11.0 Hz, J8ax13=5.0 Hz, J8ax9eq=2.5 Hz, 1H, H-
8ax), 3.84 (dd, J9eq9ax=11.5 Hz, J9eq8ax=2.5 Hz, 1H, H-9eq), 3.62 (d, J11eq11ax=11.5 Hz, 1H, H-11eq), 3.60 
(dd, J13a13b=12.0 Hz, J13a8=5.0 Hz, 1H, H-13a), 3.57 (dd, J13b13a=12.0 Hz, J13b8=6.0 Hz, 1H, H-13b), 3.56 
(dd, J12a12b=11.5 Hz, J12a2=6.0 Hz, 1H, H-12a), 3.49 (dd, J12b12a=11.5 Hz, J12b2=5.0 Hz, 1H, H-12b), 3.41 
(t, J9ax9eq=J9ax8ax=11.0 Hz, 1H, H-9ax), 3.34 (d, J11ax11eq=11.5 Hz, 1H, H-11ax), 2.68 (d, J5ax5eq=13.5 Hz, 
1H, H-5ax), 2.57 (dd, J3ax3eq=13.0 Hz, J3ax2ax=11.0 Hz, 1H, H-3ax), 2.37 (dt, J3eq3ax=13.0 Hz, 
J3eq2ax=J3eq5eq=2.0 Hz, 1H, H-3eq), 2.31 (dd, J5eq5ax=13.5 Hz, J5eq3eq=1.5 Hz, 1H, H-5eq); 13C NMR (CDCl3) 
δ/ppm 92.3 (C-6), 72.9 (C-11), 72.0 (C-2), 70.4 (C-8), 68.7 (C-9), 65.9 (C-12), 62.8 (C-13), 31.0 (C-5), 
27.5 (C-3); HRMS (ESI): calculated for C9H16O5NaS [M+Na]+ 259.0616, found 259.0620. 
4.2.5. tert-Butyl {[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}(3-{[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}thio)-{2-
[(benzyloxy)imino]propyl}carbamate (14) 
To a suspension of KH (0.125 g, 0.92 mmol) in mineral oil, was added, under argon, a solution of (S)-11c 
(0.200 g, 0.46 mmol) in THF (3 mL), followed, after 30 min, by a solution of thiol (R)-9b (0.082 mg, 
0.55 mmol) in THF (1 mL). The reaction was monitored by TLC. After adjunction of water, the mixture 
was extracted with dichloromethane (3×10 mL) and the organic extracts combined before being dried 
(MgSO4), filtered, and then the solvent was removed using a rotary evaporator. The residue was purified 
by flash chromatography on silica gel using (1:0→4:1) cyclohexane/ethyl acetate as an eluent to give 14 
as a mixture of two rotamers (0.200 g, 81%, colorless oil). IR νmax (neat, cm−1) 1697 (C O), 1250–1060 
(C–O); 1H NMR (CDCl3) δ/ppm 7.36–7.27 (m, 10H, H–Ar), 5.08 (s, 2H, CH2Ph), 5.06 (s, 2H, CH2Ph), 
4.41–4.28 (m, 4H, CH2S), 4.21 (m, 2H, CHO–CH2N), 4.17 (Q, J=6.5 Hz, 2H, SCH2–CHO), 3.98 (dd, 
2J=8.5 Hz, 3J=6.0 Hz, 2H, CH2O), 4.02–3.95 (m, 2H, CH2O), 3.59 (dd, 2J=8.5 Hz, 3J=6.5 Hz, 2H, CH2O), 
3.56 (dd, 2J=8.5 Hz, 3J=6.5 Hz, 2H, CH2O), 3.45–3.25 (m, 4H, O–CH–CH2N), 3.22 (s, 2H, NCH2), 3.18 
(s, 2H, NCH2), 2.58 (dd, 2J=13.5 Hz, 3J=6.0 Hz, 2H, SCH2), 2.46 (dd, 2J=13.5 Hz, 3J=6.5 Hz, 2H, SCH2), 
1.44 (s, 9H, t-Bu), 1.42 (s, 6H, Me), 1.41 (s, 6H, Me), 1.39 (s, 9H, t-Bu), 1.34 (s, 6H, Me), 1.33 (s, 6H, 
Me); 13C NMR (CDCl3) δ/ppm 155.5 (CO2t-Bu), 155.4 (CO2t-Bu), 155.0 (C N), 137.7 (C–Ar), 128.3 
(C–Ar), 128.1 (C–Ar), 127.8 (C–Ar), 109.5 (C–(CH3)2), 109.3 (C–(CH3)2), 80.7 (C–(CH3)3), 80.5 (C–
(CH3)3), 76.2 (CH2Ph), 76.1 (CH2Ph), 75.1 (CHO), 74.9 (CHO), 68.7 (CH2O), 67.2 (CH2O), 67.1 
(CH2O), 51.0 (CH2N), 50.7 (CH2N), 44.1 (NCH2), 44.0 (NCH2), 34.0 (SCH2), 33.8 (SCH2), 32.6 (CH2S), 
32.0 (CH2S), 28.3 (t-Bu), 26.9 (CH3), 26.8 (CH3), 25.6 (CH3), 25.5 (CH3); HRMS (ESI): calculated for 
C27H42N2O7NaS [M+Na]+ 561.2610, found 561.2603. 
4.2.6. tert-Butyl [(2S)-2,3-dihydroxypropyl]3-{[(2R)-2,3-dihydroxypropyl]thio}-{2-[(benzyloxy)imino]propyl}carbamate 
(15) 
To a solution of (S,R)-14 (0.050 g, 0.093 mmol) in a mixture of acetone/water (10:1 (v:v), 600 µL) was 
added Amberlyst® 15 (0.023 g). After stirring at reflux for 4 h, the solution was filtered on a Celite® pad 
and concentrated. The residue was purified by flash chromatography on silica gel using ethyl acetate as 
eluent to give pure (S, R)-15 (0.014 g, 33%) as a colorless oil. 1H NMR (CDCl3) two isomers E (min) and 
Z (maj) δ/ppm 7.38–7.26 (m, 10H, H–Ar, Z and E), 5.08 (s, 2H, CH2Ph, E), 5.07 (s, 2H, CH2Ph, Z), 4.42 
(d, J=16.0 Hz, 1H, CH2S, Z), 4.30–4.15 (m, 3H, CH2S, Z and E), 3.82 (m, 2H, CHO–CH2N, Z and E), 
3.73 (Q, J=6.0 Hz, 1H, CHO–CH2S, Z), 3.68 (Q, J=5.5 Hz, 1H, CHO–CH2S, E), 3.54–3.41 (m, 10H, 
CH2O, Z and E, CH2N and NCH2), 3.37–3.30 (m, 3H, CH2N and NCH2), 3.28–3.10 (m, 3H, CH2N and 
NCH2), 2.67 (m, 1H, SCH2, E), 2.56 (m, 1H, SCH2, E), 2.56 (dd, 2J=14.0 Hz, 3J=7.0 Hz, 1H, SCH2, Z), 
2.44 (dd, 2J=14.0 Hz, 3J=7.0 Hz, 1H, SCH2, Z); 13C NMR (CD3OD) δ/ppm 157.0 and 156.8 (CO2t-Bu, Z), 
155.6 (C N, Z), 155.4 (C N, E), 153.8 and 153.7 (CO2t-Bu, E), 139.3 (C–Ar, E), 139.1 (C–Ar, Z), 
129.4 (C–Ar, Z and E), 129.2 (C–Ar, Z), 129.1 (C–Ar, E), 128.9 (C–Ar, Z and E), 81.8 and 81.7 (C–
(CH3)3), 77.2 (CH2Ph, E), 77.1 (CH2Ph, Z), 72.3 (SCH2–CHO, Z), 72.2 (SCH2–CHO, E), 71.8 and 71.7 
(NCH2–CHO), 66.1 (SCH2CH–CH2O, E), 66.0 (SCH2CH–CH2O, Z), 65.4 (NCH2CH–CH2O, E), 65.1 
(NCH2CH–CH2O, Z), 53.2 (NCH2CH–CH2O, E), 52.4 (NCH2CH–CH2O, Z), 51.1 and 50.8 (N CCH2S), 
46.2 and 45.8 (N CCH2S), 36.9 and 36.7 (SCH2–CHO, E), 35.5 and 35.3 (N CCH2N, Z), 33.5 and 
33.1 (N CH2, Z), 28.7 (CH3), 26.6 and 26.2 (CH3). 
4.2.7. (2E)- and (2Z)-1-({[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl}amino)-3-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-
yl]methoxy}propanone O-benzyloxime (16) 
To a solution of (S)-11a (0.166 g; 0.51 mmol) in anhydrous methanol (1.5 mL) was added a solution of 
amine (S)-9c (0.200 g; 1.53 mmol) in methanol (0.5 mL). The resulting mixture was heated at reflux for 
4 h. The solvent was then concentrated and a saturated aqueous NaHCO3 (10 mL) solution was added. 
The mixture was extracted with dichloromethane (3×10 mL), dried (MgSO4), and concentrated in vacuo. 
The crude product was purified by flash chromatography using (7:3) ethyl acetate/cyclohexane as eluent 
to give 16 as a yellow oil (0.132 g, 61%). IR νmax (neat, cm−1) 3345 (N–H), 1590 (C N), 1255–1050 (C–
O); 1H NMR (CDCl3) δ/ppm 7.35–7.26 (m, 10H, H–Ar, E and Z), 5.09 (s, 2H, CH2Ph, E), 5.06 (s, 2H, 
CH2Ph, Z), 4.43 (d, 2J=15.5 Hz, 1H, O–CH2–C N, Z), 4.40 (d, 2J=15.5 Hz, 1H, O–CH2–C N, Z), 
4.27–4.15 (m, 4H, H–CHO, E and Z), 4.14 (d, 2J=12.0 Hz, 1H, O–CH2–C N, E), 4.12 (d, 2J=12.0 Hz, 
1H, O–CH2–C N, E), 4.05–3.96 (m, 4H, CHO–CH2O, Z and E), 3.72 (dd, 2J′=8.0 Hz, 3J=6.5 Hz, 1H, 
O–CH2–CHO, Z), 3.67 (dd, 2J=8.5 Hz, 3J=6.5 Hz, 1H, O–CH2–CHO, E), 3.62 (dd, 2J=8.0 Hz, 3J=7.0 Hz, 
2H, NHCH2CH–CH2O, E and Z), 3.58 (d, 2J=15.0 Hz, 1H, CH2NH, E), 3.57 (d, 2J=15.0 Hz, 1H, CH2NH, 
E), 3.53–3.40 (m, 6H, CH2–O–CH2C N, E and Z, C–CH2NH, Z), 2.72–2.62 (m, 4H, NH–CH2, Z and 
E), 1.91 (br s, 2H, NH, E and Z), 1.40 and1.38 (s, 12H, Me, Z and E), 1.34 and 1.33 (s, 12H, Me, Z and 
E); 13C NMR (CDCl3) δ/ppm 156.9 (C N, Z), 156.6 (C N, E), 137.6 (C–Ar, Z), 137.5 (C–Ar, E), 
128.3 (C–Ar, Z and E), 128.0 (C–Ar, Z and E), 127.8 (C–Ar, Z and E), 109.4 (C–(CH3)2, Z and E), 109.0 
(C–(CH3)2, Z and E), 76.0 (CH2Ph, Z and E), 75.3 (NHCH2CHO, Z), 75.1 (NHCH2CHO, E), 74.4 
(CHOCH2O, E), 74.3 (CHOCH2O, Z), 72.3 (CHOCH2O, Z), 71.2 (CHOCH2O, E), 70.6 (O–CH2–C N, 
E), 67.5 (NHCH2CHOCH2, Z), 67.4 (NHCH2CHOCH2, E), 66.6 (OHCH2CHOCH2, E), 66.5 
(OHCH2CHOCH2, Z), 66.3 (OCH2C N, Z), 52.2 (NH–CH2–CHO, E), 51.5 (NH–CH2–CHO, Z), 49.1 
(N C–CH2–NH, Z), 44.9 (N C–CH2–NH, E), 26.9 (CH3, Z), 26.8 (CH3, E), 26.8 (CH3, Z and E), 25.4 
(CH3, Z and E), 25.3 (CH3, Z and E); HRMS (ESI): calculated for C22H35N2O6 [M+H]+ 423.2495, found 
423.2497. 
4.2.8. (2E)- and (2Z)-1-({[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl}amino)-3-({[(4R)-2,2-dimethyl-1,3-dioxolan-4-
yl]methyl}thio)propanone O-benzyloxime (17) 
To a solution of (R)-11b (0.150 g, 0.44 mmol) in 1 mL of anhydrous methanol was added a solution of 
amine (S)-9c (0.172 g; 1.31 mmol) in methanol (0.5 mL). The resulting mixture was stirred under reflux 
for 8 h. The solution was then concentrated in vacuo and a saturated aqueous solution of NaHCO3 (7 mL) 
followed by dichloromethane (15 mL) was introduced. After extraction, the organic layer was dried 
(MgSO4) and concentrated. The crude product was then purified by flash chromatography using 
(1:1→7:3) ethyl acetate/cyclohexane as eluent to give pure 17 as a yellow oil (0.128 mg; 67%). 
Compound 17 appeared as a mixture of Z and E isomers. IR νmax (neat, cm−1) 3341 (N–H), 1624 (C N), 
1250–1050 (C–O); 1H NMR (CDCl3) δ/ppm 7.36–7.27 (m, 10H, H–Ar, Z and E), 5.08 (s, 4H, CH2Ph, Z 
and E), 4.24–4.14 (m, 4H, CHO, Z and E), 4.00 (dd, 2J=8.0 Hz, 3J=6.5 Hz, 1H, NCH2CHCH2O, Z), 4.02–
3.96 (m, 2H, NCH2CHCH2O, E and SCH2CHCH2O, E), 3.95 (dd, 2J=8.5 Hz, 3J=6.0 Hz, 1H, 
SCH2CHCH2O, Z), 3.67–3.55 (m, 6H, SCH2CHCH2O (Z and E), NCH2CHCH2O (Z and E), N CCH2N, 
E), 3.48 (s, 2H, N CCH2N, Z), 3.46 (s, 2H, N CCH2N, Z), 3.32 (d, 2J=13.5 Hz, 1H, SCH2C N, E), 
3.29 (d, 2J=13.5 Hz, 1H, SCH2C N, E), 2.70 (dd, 2J=13.5 Hz, 3J=6.5 Hz, 1H, OCHCH2S, Z), 2.67 (d, 
3J=6.0 Hz, 4H, NHCH2CHO, E and Z), 2.59 (dd, 2J=13.5 Hz, 3J=6.5 Hz, 1H, OCHCH2S, E), 2.56 (dd, 
2J=13.5 Hz, 3J=6.5 Hz, 1H, OCHCH2S, Z), 2.47 (dd, 2J=13.5 Hz, 3J=6.5 Hz, 1H, OCHCH2S, E), 1.64 (br 
s, 2H, NH, E and Z), 1.41 (s, 6H, Me, E and Z), 1.40 (s, 6H, Me, E and Z), 1.34 (s, 6H, Me, E and Z), 1.32 
(s, 6H, Me, E and Z); 13C NMR (CDCl3) δ/ppm 156.5 (C N, E), 155.8 (C N, Z), 137.7 (C–Ar, E), 
137.4 (C–Ar, Z), 128.3 (C–Ar, Z and E), 128.0 (C–Ar, Z and E), 127.9 (C–Ar, Z), 127.8 (C–Ar, E), 109.4 
(C–(CH3)2, Z and E), 109.1 (C–(CH3)2, Z and E), 76.0 (CH2Ph, Z and E), 75.2 (NHCH2–CHO, Z), 75.1 
(NHCH2–CHO, E), 74.8 (SCH2–CHO, Z and E), 68.6 (SCH2CHCH2O, Z and E), 67.4 (NHCH2CHCH2O, 
Z), 67.3 (NHCH2CHCH2O, E), 52.1 (NH–CH2–CHO, E), 51.5 (NH–CH2–CHO, Z), 50.2 (N C–CH2, Z), 
45.0 (N C–CH2, E), 35.2 (S–CH2–CHO, Z), 33.8 (S–CH2–CHO, E), 33.2 (S–CH2–C N, E), 26.9 
(CH3, E), 26.8 (CH3, Z), 25.6 (CH3, E), 25.4 (CH3, Z), 25.5 (CH3, Z and E), 25.3 (S–CH2–C N, Z); 
HRMS (ESI): calculated for C22H35N2O5S [M+H]+ 439.2267, found 439.2251. 
4.2.9. N-{[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl}-N-3-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy}-2-
{[(benzyloxy)imino]propyl}benzamide (18) 
To (S,S)-16 (0.317 g, 0.75 mmol) in anhydrous dichloromethane (8 mL) were added at 0 °C and under 
argon, triethylamine (155 µL, 1.13 mmol) and 4-dimethylaminopyridine (0.018 mg, 0.15 mmol). After 
15 min, benzoylchloride (105 µL, 0.90 mmol) was added dropwise to the reaction mixture. The solution 
was quenched with H2O after 2 h and the mixture was extracted with dichloromethane. The combined 
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo. The crude product was 
purified by silica gel chromatography using (3:2) cyclohexane/ethyl acetate as eluant to give 18 as a 
colorless oil (0.355 g, 90%). Compound 18 is made of a mixture of the two isomers Z and E. IR νmax 
(neat, cm−1) 1635 (C O), 1260–1000 (C–O); 1H NMR (CDCl3) δ/ppm 7.40–7.20 (m, 10H, H–Ar), 5.16–
5.00 (m, 2H, CH2Ph), 4.69–3.75 (m, 8H, CHO, CH2O, O–CH2–C ), 3.75–3.15 (m, 6H, CHO–CH2–O, 
N–CH2–CHO, C–CH2–N), 1.40–1.20 (m, 12H, Me); 13C NMR (CDCl3) δ/ppm 172.6 (C , E and Z), 
153.8 (NCO, E and Z), 137.7 (C–Ar–Bn, E and Z), 136.2 (C–Ar, Z), 135.8 (C–Ar, E), 129.5 (C–Ar, E), 
129.3 (C–Ar, Z), 128.3 (C–Ar–Bn, E and Z), 128.2 (C–Ar, E and Z), 128.0 (C–Ar–Bn, E and Z), 127.0 
(C–Ar–Bn, E and Z), 126.4 (C–Ar, E and Z), 109.4 (C–(CH3)2, Z), 109.1 (C–(CH3)2, E), 76.4 (CH2–Ph, 
Z), 76.2 (CH2–Ph, E), 75.1 (NCH2–CHO, Z), 74.4 (NCH2–CHO, E), 74.2 (OCH2–CHO, E and Z), 72.5 
(CHO–CH2–O, E), 72.0 (CHO–CH2–O, Z), 67.4–66.9–66.6–66.3–65.8–65.5 (CH2–O, O–CH2–C , E 
and Z), 51.8 (N–CH2–CHO, E), 50.3 (N–CH2–CHO, Z), 48.1 ( C–CH2–N, Z), 44.6 ( C–CH2–N, E), 
26.8–26.7–26.6–25.4–25.3 (CH3, E and Z); HRMS (ESI): calculated for C29H38N2O7Na [M+Na]+ 
549.2577, found 549.2572. 
4.2.10. N-{[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl}-N-[3-({[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}-thio)-2-
[(benzyloxy)imino]propyl]benzamide (19) 
Compound 17 (0.350 g; 0.80 mmol) was dissolved in anhydrous dichloromethane (8 mL) at 0 °C and 
under argon. Triethylamine (170 µL, 1.20 mmol) and 4-dimethylaminopyridine (0.020 g, 0.16 mmol) 
were added followed by benzoylchloride (110 µL, 0.96 mmol). The mixture was stirred at 0 °C for 2 h 
whereupon the reaction was stopped by addition of water, extracted with ethyl acetate, and dried 
(MgSO4). After evaporation of the solvent, the crude product was purified by flash chromatography using 
(7:3) cyclohexane/ethyl acetate as eluent to give pure 19 (0.412 mg, 95%) as a colorless oil. IR νmax (neat, 
cm−1) 1638 (C O), 1260–1060 (C–O); 1H NMR (CDCl3) δ/ppm 7.40–7.26 (m, 10H, H–Ar), 5.09 (s, 2H, 
CH2Ph), 4.67–3.74 (m, 6H, CHO, CH2O), 3.73–3.00 (m, 6H, N–CH2–CHO, S–CH2–C N and N C–
CH2N), 2.82–2.20 (m, 2H, CHO–CH2–S), 1.45–1.20 (m, 12H, Me); 13C NMR (CDCl3) δ/ppm 172.5 (C
N, E), 172.4 (C N, Z), 152.1 (C O, E and Z), 137.3 (COC–Ar, E and Z), 135.9 (COC–Ar, Z), 135.7 
(COC–Ar, E), 129.6 (COC–Ar, E), 129.4 (COC–Ar, Z), 128.6, 128.3, 128.2, 128.1, 128.0, 127.9, 127.0 
and 126.5 (C–Ar, E and Z), 109.4 (C–(CH3)2, Z), 109.2 (C–(CH3)2, E), 76.4 (CH2Ph, E), 76.3 (CH2Ph, Z), 
74.9, 74.8 and 74.6 (CHO, E and Z), 68.6 (CH2–CHOCH2S, E), 68.5 (CH2–CHOCH2S, Z), 67.2 (CH2–
CHOCH2N, Z), 66.8 (CH2–CHOCH2N, E), 51.6 (N–CH2–CHO, Z), 47.9 (N CCH2, Z), 46.1 (N–CH2–
CHO, E), 42.6 (N CCH2, E), 35.5 (CHO–CH2S, E), 34.7 (CHO–CH2S, Z), 34.1 and 33.4 (S–CH2–C
N, E), 26.8 (CH3, E and Z), 26.0 (S–CH2–C N, Z), 25.4 (CH3, E and Z); HRMS (ESI): calculated for 
C29H38N2O6NaS [M+Na]+ 565.2348, found 565.2374. 
4.2.11. (2R,8S)-2,8-Dihydroxymethyl-10-benzoyl-10-aza-1,4,7-trioxaspiro[5.5]undecane (20) 
A solution of (S,S)-18 (0.150 g, 0.28 mmol) in 2.8 mL of a 10:1 (v/v) mixture of acetone/water and 
Amberlyst® 15 (0.070 g) was heated for 2 days under reflux with 2.8 mmol of paraformaldehyde. After 
cooling and filtration on a Celite® pad, the solvent was evaporated in vacuo and the crude mixture was 
purified by flash chromatography using (49:1) ethyl acetate/MeOH as eluent to give a mixture of isomers 
20 as a colorless oil (0.056 g, 61%). IR νmax (neat, cm−1) 3400 (O–H), 1618 (C O), 1051 (C–O); 13C 
NMR (DMSO-d6, 293 K) δ/ppm 170.6–170.4–170.0–169.6 (C–Ar), 136.7–135.3 (C–Ar), 129.7–129.4 
(C–Ar), 128.4–128.2 (C–Ar), 127.3–127.0–126.8 (C–Ar), 92.1–91.6 (C-6), 73.4–73.2–71.9–69.0–67.8–
67.4 (C-3 and C-5), 72.8–72.4–70.5–70.3–68.6 (C-2 and C-8), 63.0–62.9–62.8–61.9–61.6–61.0 (C-12 and 
C-13), 52.2–50.7–50.3–48.6–46.4–45.1–44.9–43.4 (C-9 and C-11); HRMS (ESI): calculated for 
C16H21NO6Na [M+Na]+ 346.1267, found 346.1261. 
4.2.12. (2R,8S)-2,8-Dihydroxymethyl-10-benzoyl-10-aza-4-thia-1,7-dioxaspiro[5.5]undecane (21) 
A solution of oxime (R,S)-19 (0.112 g, 0.20 mmol) in 2 mL of a 10:1 (v/v) mixture of acetone/water with 
Amberlyst®15 (0.050 g) and 2 mmol of paraformaldehyde was heated under reflux for 2 days. After 
cooling and filtration on a Celite® pad, the solvent was evaporated in vacuo and the crude mixture 
purified by silica gel chromatography using (1:0→49:1) ethyl acetate/MeOH as eluent to give 21 as a 
white syrup (0.045 g, 65%). IR νmax (neat, cm−1) 3394 (O–H), 1618 (C O), 1047 (C–O); 13C NMR 
(DMSO-d6, 293 K) δ/ppm 170.1–169.4 (N–CO), 135.7 (C–Ar), 129.4 (C–Ar), 128.4–128.2 (C–Ar), 
127.3–126.6 (C–Ar), 91.6–91.2 (C-6), 70.3–70.2 (C-2), 68.7 (C-8), 63.9–63.8–61.9–61.5 (C-12 and C-
13), 54.1–48.5–43.5 (C-9 and C-11), 30.8–30.5 (C-5), 26.6 (C-3); HRMS (ESI): calculated for 
C16H21NO5NaS [M+Na]+ 362.1038, found 362.1021. 
4.2.13. 2,8-Dihydroxymethyl-10-benzoyl-10-aza-1,4,7-trioxaspiro[5.5]undecane (22) 
To a solution of spiroketal 20 (0.056 g, 0.17 mmol) in THF (1 mL) was added at 0 °C and under argon, a 
1.0 M solution of LiAlH4 in THF (693 µL, 0.68 mmol). After 3 h, the reaction is quenched by adjunction 
of water and the residue filtered over MgSO4. The solvent was eliminated to give nearly quantitatively a 
crude and inseparable mixture of isomers 22, in a 4:1 ratio as determined from 13C NMR. 13C NMR 
(CDCl3) δ/ppm 105.9–91.6 (C-6), 75.0–70.0 (C-8), 72.6–70.0 (C-5), 70.6–69.0 (C-2), 68.4–67.2 (C-3), 
63.7–63.4 (CH2OH), 62.5–62.0 (CH2OH), 49.9–49.1 (C-11), 47.9–46.1 (C-9). 
Major isomer: (2R,6S,8S)-22a: 1H NMR (CDCl3) δ/ppm 4.06 (m, 1H, H-2), 3.90 (m, 1H, H-8), 3.60–3.48 
(m, 4H, CH2OH), 3.74 (dd, J3eq3ax=11.0 Hz, J3eq2ax=2.5 Hz, 1H, H-3eq), 3.60 (d, 2J=11.5 Hz, 1H, H-5), 
3.33 (t, J3ax3eq=J3ax2ax=11.0 Hz, 1H, H-3ax), 3.26 (d, 2J=11.5 Hz, 1H, H-5), 3.13 (br d, 1H, NH), 2.83 (br d, 
J9eq9ax=12.0 Hz, 1H, H-9eq), 2.73 (d, 2J=13.0 Hz, 1H, H-11), 2.57 (t, J9ax9eq=J9ax8ax=12.0 Hz, 1H, H-9ax), 
2.52 (d, 2J=13.0 Hz, 1H, H-11); 13C NMR (CDCl3) δ/ppm 91.6 (C-6), 70.0 (C-8), 70.0 (C-5), 69.0 (C-2), 
67.2 (C-3), 63.4 (CH2OH), 62.0 (CH2OH), 49.1 (C-11), 46.1 (C-9); HRMS (ESI): calculated for 
C9H18NO5 [M+H]+ 220.1185, found 220.1175. 
4.2.14. 2,8-Dihydroxymethyl-10-benzoyl-10-aza-4-thia-1,7-dioxaspiro[5.5]undecane (23) 
To a solution of spiroketal 21 (0.060 g, 0.18 mmol) in THF (1 mL) was added at 0 °C and under argon, a 
1.0 M solution of LiAlH4 in THF (710 µL, 0.72 mmol). After 3 h, the reaction is quenched by adjunction 
of water and the residue filtered over MgSO4. The solvent was eliminated to give nearly quantitatively a 
crude and inseparable mixture of isomers 23, in a 9:1 ratio (determined from 13C NMR). 13C NMR 
(CDCl3) δ/ppm 99.9–90.9 (C-6), 71.4–70.8 (C-2), 70.8–70.2 (C-8), 68.8–63.3 (CH2OH), 65.2–65.2 
(CH2OH), 53.0–51.6 (C-11), 47.7–46.1 (C-9), 37.0*–32.0 (C-5), 36.6*–26.2 (C-3). 
Major isomer: (2R,6S,8S)-23a: 1H NMR (CDCl3) δ/ppm 4.04 (m, 1H, H-2), 3.89 (m, 1H, H-8), 3.58–3.45 
(m, 4H, CH2OH), 2.81 (br d, J9eq9ax=12.0 Hz, 1H, H-9eq), 2.79 (d, 2J=13.0 Hz, 1H, H-11), 2.67 (d, 
2J=13.5 Hz, 1H, H-5), 2.57 (d, 2J=13.0 Hz, 1H, H-11), 2.51 (t, J9ax9eq=J9ax8ax=12.0 Hz, 1H, H-9ax), 2.48 (t, 
J3ax3eq=J3ax2ax=12.0 Hz, 1H, H-3ax), 2.29 (d, 2J=13.5 Hz, 1H, H-5), 2.18 (br d, J3eq3ax=13.0 Hz, 1H, H-3eq); 
13C NMR (CDCl3) δ/ppm 90.9 (C-6), 70.8 (C-2), 70.2 (C-8), 65.2 (CH2OH), 63.3 (CH2OH), 53.0 (C-11), 
46.1 (C-9), 32.0 (C-5), 26.2 (C-3); HRMS (ESI): calculated for C9H18NO4S [M+H]+ 236.0957, found 
236.0946. 
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